Field evaluation of safety during gestation and horizontal spread of a recombinant differential bovine herpesvirus 1 (BoHV-1) vaccine

Fernando R. Spilki, Alessandra D. Silva, Helena Beatriz C Ruthner Batista, Anna P. Oliveira, Evandro Winkelmann, Ana C. Franco, Jorge A. Porciúncula, Paulo Michel Roehe

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Bovine herpesvirus type 1 (BoHV-1) is recognized as a major cause of respiratory, reproductive disease and abortion in cattle. Vaccination is widely applied to minimize losses induced by BoHV-1 infections; however, vaccination of dams during pregnancy with modified live virus (MLV) vaccines has been occasionally associated to abortions. We have previously reported the development of a BoHV-1 recombinant virus, constructed with basis on a Brazilian BoHV-1 (Franco et al. 2002a) from which the gene coding for glycoprotein E (gE) was deleted (gE-) by genetic manipulation. Such recombinant has been previously evaluated in its potential as a differential vaccine (gE-vaccine) that allows differentiation between vaccinated and infected animals. Here, in the first part of the present study, the safety of the gE-vaccine during pregnancy was evaluated by the intramuscular inoculation of 107.4 tissue culture 50% infective doses (TCID50) of the virus into 22 pregnant dams (14 BoHV-1 seronegative; 8 seropositive), at different stages of gestation. Other 15 pregnant dams were kept as non-vaccinated controls. No abortions, stillbirths or fetal abnormalities were seen after vaccination. Seroconversion was observed in both groups of previously seronegative vaccinated animals. In the second part of the study, the potential of the gE-vaccine virus to spread among beef cattle under field conditions was examined. Four heifers were inoculated intranasally with a larger amount (107.6TCID50) of the gE-vaccine (to increase chances of transmission) and mixed with other sixteen animals at the same age and body condition, in the same grazing area, at a population density equal to the average cattle farming density within the region (one cattle head per 10,000 m2), for 180 days. All animals were monitored daily for clinical signs. Serum samples were collected on days 0, 30, 60 and 180 post-vaccination. Seroconversion was observed only in vaccinated heifers. These results indicate that, under the conditions of the present study, the gE-vaccine virus did not cause any noticeable harmful effect on pregnant dams and on its offspring and did not spread horizontally among cattle.

Original languageEnglish (US)
Pages (from-to)54-58
Number of pages5
JournalPesquisa Veterinaria Brasileira
Volume25
Issue number1
StatePublished - Jan 2005
Externally publishedYes

Fingerprint

Herpesvirus Vaccines
Bovine Herpesvirus 1
Bovine herpesvirus 1
glycoproteins
Glycoproteins
Vaccines
pregnancy
vaccines
Safety
Pregnancy
vaccination
abortion (animals)
Viruses
Vaccination
viruses
cattle
seroconversion
heifers
animals
Herpesviridae Infections

Keywords

  • BoHV-1 recombinant gE-vaccine
  • Bovine herpesvirus 1

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Spilki, F. R., Silva, A. D., Ruthner Batista, H. B. C., Oliveira, A. P., Winkelmann, E., Franco, A. C., ... Roehe, P. M. (2005). Field evaluation of safety during gestation and horizontal spread of a recombinant differential bovine herpesvirus 1 (BoHV-1) vaccine. Pesquisa Veterinaria Brasileira, 25(1), 54-58.

Field evaluation of safety during gestation and horizontal spread of a recombinant differential bovine herpesvirus 1 (BoHV-1) vaccine. / Spilki, Fernando R.; Silva, Alessandra D.; Ruthner Batista, Helena Beatriz C; Oliveira, Anna P.; Winkelmann, Evandro; Franco, Ana C.; Porciúncula, Jorge A.; Roehe, Paulo Michel.

In: Pesquisa Veterinaria Brasileira, Vol. 25, No. 1, 01.2005, p. 54-58.

Research output: Contribution to journalArticle

Spilki, FR, Silva, AD, Ruthner Batista, HBC, Oliveira, AP, Winkelmann, E, Franco, AC, Porciúncula, JA & Roehe, PM 2005, 'Field evaluation of safety during gestation and horizontal spread of a recombinant differential bovine herpesvirus 1 (BoHV-1) vaccine', Pesquisa Veterinaria Brasileira, vol. 25, no. 1, pp. 54-58.
Spilki FR, Silva AD, Ruthner Batista HBC, Oliveira AP, Winkelmann E, Franco AC et al. Field evaluation of safety during gestation and horizontal spread of a recombinant differential bovine herpesvirus 1 (BoHV-1) vaccine. Pesquisa Veterinaria Brasileira. 2005 Jan;25(1):54-58.
Spilki, Fernando R. ; Silva, Alessandra D. ; Ruthner Batista, Helena Beatriz C ; Oliveira, Anna P. ; Winkelmann, Evandro ; Franco, Ana C. ; Porciúncula, Jorge A. ; Roehe, Paulo Michel. / Field evaluation of safety during gestation and horizontal spread of a recombinant differential bovine herpesvirus 1 (BoHV-1) vaccine. In: Pesquisa Veterinaria Brasileira. 2005 ; Vol. 25, No. 1. pp. 54-58.
@article{1134a2551e1341ff8ae60c6d32bd4f23,
title = "Field evaluation of safety during gestation and horizontal spread of a recombinant differential bovine herpesvirus 1 (BoHV-1) vaccine",
abstract = "Bovine herpesvirus type 1 (BoHV-1) is recognized as a major cause of respiratory, reproductive disease and abortion in cattle. Vaccination is widely applied to minimize losses induced by BoHV-1 infections; however, vaccination of dams during pregnancy with modified live virus (MLV) vaccines has been occasionally associated to abortions. We have previously reported the development of a BoHV-1 recombinant virus, constructed with basis on a Brazilian BoHV-1 (Franco et al. 2002a) from which the gene coding for glycoprotein E (gE) was deleted (gE-) by genetic manipulation. Such recombinant has been previously evaluated in its potential as a differential vaccine (gE-vaccine) that allows differentiation between vaccinated and infected animals. Here, in the first part of the present study, the safety of the gE-vaccine during pregnancy was evaluated by the intramuscular inoculation of 107.4 tissue culture 50{\%} infective doses (TCID50) of the virus into 22 pregnant dams (14 BoHV-1 seronegative; 8 seropositive), at different stages of gestation. Other 15 pregnant dams were kept as non-vaccinated controls. No abortions, stillbirths or fetal abnormalities were seen after vaccination. Seroconversion was observed in both groups of previously seronegative vaccinated animals. In the second part of the study, the potential of the gE-vaccine virus to spread among beef cattle under field conditions was examined. Four heifers were inoculated intranasally with a larger amount (107.6TCID50) of the gE-vaccine (to increase chances of transmission) and mixed with other sixteen animals at the same age and body condition, in the same grazing area, at a population density equal to the average cattle farming density within the region (one cattle head per 10,000 m2), for 180 days. All animals were monitored daily for clinical signs. Serum samples were collected on days 0, 30, 60 and 180 post-vaccination. Seroconversion was observed only in vaccinated heifers. These results indicate that, under the conditions of the present study, the gE-vaccine virus did not cause any noticeable harmful effect on pregnant dams and on its offspring and did not spread horizontally among cattle.",
keywords = "BoHV-1 recombinant gE-vaccine, Bovine herpesvirus 1",
author = "Spilki, {Fernando R.} and Silva, {Alessandra D.} and {Ruthner Batista}, {Helena Beatriz C} and Oliveira, {Anna P.} and Evandro Winkelmann and Franco, {Ana C.} and Porci{\'u}ncula, {Jorge A.} and Roehe, {Paulo Michel}",
year = "2005",
month = "1",
language = "English (US)",
volume = "25",
pages = "54--58",
journal = "Pesquisa Veterinaria Brasileira",
issn = "0100-736X",
publisher = "Colegio Brasileiro de Patologia Animal",
number = "1",

}

TY - JOUR

T1 - Field evaluation of safety during gestation and horizontal spread of a recombinant differential bovine herpesvirus 1 (BoHV-1) vaccine

AU - Spilki, Fernando R.

AU - Silva, Alessandra D.

AU - Ruthner Batista, Helena Beatriz C

AU - Oliveira, Anna P.

AU - Winkelmann, Evandro

AU - Franco, Ana C.

AU - Porciúncula, Jorge A.

AU - Roehe, Paulo Michel

PY - 2005/1

Y1 - 2005/1

N2 - Bovine herpesvirus type 1 (BoHV-1) is recognized as a major cause of respiratory, reproductive disease and abortion in cattle. Vaccination is widely applied to minimize losses induced by BoHV-1 infections; however, vaccination of dams during pregnancy with modified live virus (MLV) vaccines has been occasionally associated to abortions. We have previously reported the development of a BoHV-1 recombinant virus, constructed with basis on a Brazilian BoHV-1 (Franco et al. 2002a) from which the gene coding for glycoprotein E (gE) was deleted (gE-) by genetic manipulation. Such recombinant has been previously evaluated in its potential as a differential vaccine (gE-vaccine) that allows differentiation between vaccinated and infected animals. Here, in the first part of the present study, the safety of the gE-vaccine during pregnancy was evaluated by the intramuscular inoculation of 107.4 tissue culture 50% infective doses (TCID50) of the virus into 22 pregnant dams (14 BoHV-1 seronegative; 8 seropositive), at different stages of gestation. Other 15 pregnant dams were kept as non-vaccinated controls. No abortions, stillbirths or fetal abnormalities were seen after vaccination. Seroconversion was observed in both groups of previously seronegative vaccinated animals. In the second part of the study, the potential of the gE-vaccine virus to spread among beef cattle under field conditions was examined. Four heifers were inoculated intranasally with a larger amount (107.6TCID50) of the gE-vaccine (to increase chances of transmission) and mixed with other sixteen animals at the same age and body condition, in the same grazing area, at a population density equal to the average cattle farming density within the region (one cattle head per 10,000 m2), for 180 days. All animals were monitored daily for clinical signs. Serum samples were collected on days 0, 30, 60 and 180 post-vaccination. Seroconversion was observed only in vaccinated heifers. These results indicate that, under the conditions of the present study, the gE-vaccine virus did not cause any noticeable harmful effect on pregnant dams and on its offspring and did not spread horizontally among cattle.

AB - Bovine herpesvirus type 1 (BoHV-1) is recognized as a major cause of respiratory, reproductive disease and abortion in cattle. Vaccination is widely applied to minimize losses induced by BoHV-1 infections; however, vaccination of dams during pregnancy with modified live virus (MLV) vaccines has been occasionally associated to abortions. We have previously reported the development of a BoHV-1 recombinant virus, constructed with basis on a Brazilian BoHV-1 (Franco et al. 2002a) from which the gene coding for glycoprotein E (gE) was deleted (gE-) by genetic manipulation. Such recombinant has been previously evaluated in its potential as a differential vaccine (gE-vaccine) that allows differentiation between vaccinated and infected animals. Here, in the first part of the present study, the safety of the gE-vaccine during pregnancy was evaluated by the intramuscular inoculation of 107.4 tissue culture 50% infective doses (TCID50) of the virus into 22 pregnant dams (14 BoHV-1 seronegative; 8 seropositive), at different stages of gestation. Other 15 pregnant dams were kept as non-vaccinated controls. No abortions, stillbirths or fetal abnormalities were seen after vaccination. Seroconversion was observed in both groups of previously seronegative vaccinated animals. In the second part of the study, the potential of the gE-vaccine virus to spread among beef cattle under field conditions was examined. Four heifers were inoculated intranasally with a larger amount (107.6TCID50) of the gE-vaccine (to increase chances of transmission) and mixed with other sixteen animals at the same age and body condition, in the same grazing area, at a population density equal to the average cattle farming density within the region (one cattle head per 10,000 m2), for 180 days. All animals were monitored daily for clinical signs. Serum samples were collected on days 0, 30, 60 and 180 post-vaccination. Seroconversion was observed only in vaccinated heifers. These results indicate that, under the conditions of the present study, the gE-vaccine virus did not cause any noticeable harmful effect on pregnant dams and on its offspring and did not spread horizontally among cattle.

KW - BoHV-1 recombinant gE-vaccine

KW - Bovine herpesvirus 1

UR - http://www.scopus.com/inward/record.url?scp=20044391823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044391823&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:20044391823

VL - 25

SP - 54

EP - 58

JO - Pesquisa Veterinaria Brasileira

JF - Pesquisa Veterinaria Brasileira

SN - 0100-736X

IS - 1

ER -